Jasinski announced the move on Tuesday at the medical technology convention AdvaMed 2012 in Boston. On Wednesday, he said in a phone interview that Argo will be opening up an office in Marlborough by the end of the year.

Argo Medical Technologies is a manufacturer of the ReWalk device, an exoskeletal device that, according to the company’s website, allows paraplegic patients with spinal cord injuries caused from accidents or disease to stand, walk and climb stairs.

"It’s a very unique and different kind of technology," said Jasinski. "The mission of this company is really to improve the health and life experience of people with spinal cord injuries."

He said that while production of Argo products will remain overseas, the Marlborough location will serve administrative and marketing purposes and will function as a service center for people who use the devices stateside.

"With these devices, if you have any problems, there has to be a very good service capability," said Jasinski. "Marlborough is going to be really important because it is going to be the service center for us."

Jasinski said the Marlborough office will be located at 33 Locke Drive in a building with other medical offices. He said the company signed the lease last month.

The Marlborough office will start off with a few employees, but Jasinski said he hopes to create about 40 new jobs within the next few years, assuming the Food and Drug Administration approves the ReWalk device. He said the company plans to file the FDA application next month.

Jasinski said Argo Medical Technologies was drawn to the state as a whole because of the prominence of medical, medical technology and life science firms as well as the high quality of the colleges and universities and Marlborough specifically because of its geography, right near interstates 495 and 90.

No state cash was used as an incentive to draw the company to Massachusetts, Jasinski said.

"We’re really excited to see them come to Marlborough," she said. "We’re just thrilled to have a company with this kind of transformative technology."

Windham-Bannister said that while the eventual goal is to find procedures and treatments that can reverse paralysis and treat spinal cord injuries, drug trials are painstakingly long processes. She said its important to have companies like Argo and who provide substantive ways to improve the quality of life for patients in the interim through medical technology and robotics.